SEATTLE, Dec. 26 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) management to hold a conference call tomorrow (Thursday, December 27) at 8:30 am EST to discuss update on Zevalin asset purchase, CMS reimbursement, and PIX301 timing for results.
http://www.cticseattle.commedia@ctiseattle.comhttp://www.cticseattle.com/media.htminvest@ctiseattle.comhttp://www.cticseattle.com/investors.htm
CONTACT: media, Dan Eramian, +1-206-272-4343, cell, +1-206-854-1200, or
Susan Callahan, +1-206-272-4472, fax, +1-206-272-4434,
media@ctiseattle.com, or investors, Leah Grant, +1-206-282-7100, fax,
+1-206-272-4434, invest@ctiseattle.com, all of Cell Therapeutics, Inc.
Web site: http://www.cticseattle.com/
